Hypoxia Selectively Impairs CAR-T Cells In Vitro

Area of Science:

• Immunology
• Cancer Biology
• Cellular Physiology

Background:

• Solid tumors often exhibit a hypoxic microenvironment.
• Chimeric antigen receptor-T (CAR-T) cell therapy shows promise but faces challenges in solid tumors.

Purpose of the Study:

• To investigate the impact of hypoxia on CAR-T cell function.
• To characterize CAR-T cells cultured and tested under varying oxygen conditions.

Main Methods:

• CD19- and BCMA-specific human CAR-T cells were cultured at atmospheric (18% O2) and hypoxic (1% O2) conditions.
• CAR-T cell expansion, differentiation, CD4:CD8 ratio, cytotoxicity, cytokine secretion, granzyme B release, and PD-1 upregulation were assessed.

Main Results:

• Hypoxic culture significantly reduced CAR-T cell expansion and led to a less differentiated phenotype with a higher CD4:CD8 ratio.
• Cytokine production and granzyme B release were decreased in hypoxic conditions, irrespective of initial CAR-T cell culture conditions.
• Cytolytic activity and PD-1 upregulation remained comparable between atmospheric and hypoxic CAR-T cells.

Conclusions:

• Hypoxia impairs critical CAR-T cell functions, including expansion, differentiation, and effector molecule secretion.
• These hypoxia-induced deficits may contribute to the limited efficacy of CAR-T cell therapy in solid tumors.
• Strategies to overcome hypoxia-mediated CAR-T cell dysfunction are needed for improved solid tumor treatment.